Back to search

Article

COVID-19 Infection, Admission and Death Amongst People with Rare Autoimmune Rheumatic Disease in England. Results from the RECORDER Project

2021-08-18

Abstract excerpt

<h4>Objectives</h4> To calculate the rates of COVID-19 infection and COVID-19-related death among people with rare autoimmune rheumatic diseases (RAIRD) during the first wave of the COVID-19 pandemic in England compared to the general population. <h4>Methods</h4> We used Hospital Episode Statistics to identify all people alive 01 March 2020 with ICD-10 codes for RAIRD from the whole population of England. We used...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
dea78cc7-3d60-527d-860a-47033dfc2bcd
DOI
10.1101/2021.08.17.21260846
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
COVID-19 Infection, Admission and Death Amongst People with Rare Autoimmune Rheumatic Disease in England. Results from the RECORDER ProjectDOI 10.1101/2021.08.17.21260846
Risk of death among people with rare autoimmune diseases compared to the general population in England during the 2020 COVID-19 pandemicSemantic proximity
Incidence and management of inflammatory arthritis in England before and during the COVID-19 pandemic: a population-level cohort study using OpenSAFELYSemantic proximity
Temporal trends in COVID-19 outcomes among patients with systemic autoimmune rheumatic diseases: From the first wave to OmicronSemantic proximity
Different Covid-19 Outcomes Among Systemic Rheumatic Diseases: A Nation-wide Cohort StudySemantic proximity
Association of COVID-19 with risks of hospitalization and mortality from other disorders post-infection: A study of the UK BiobankSemantic proximity
Assessment of Impact of the COVID-19 Pandemic from the Perspective of Patients with Rheumatic and Musculoskeletal Diseases in Europe: Results from the REUMAVID Study (Phase 1)Semantic proximity
Covid 19 Infection in Patients with Rheumatic Immune-Mediated Diseases in a Single University Hospital. Matched Case-Control Study and Literature Review.Semantic proximity
Risk of severe COVID-19 outcomes associated with immune-mediated inflammatory diseases and immune modifying therapies: a nationwide cohort study in the OpenSAFELY platformSemantic proximity
Outcomes with and without outpatient SARS-CoV-2 treatment for patients with COVID-19 and systemic autoimmune rheumatic diseases: A retrospective cohort studySemantic proximity
Estimating excess 1- year mortality from COVID-19 according to underlying conditions and age in England: a rapid analysis using NHS health records in 3.8 million adultsSemantic proximity
COVID-19 in rheumatic diseases: A random cross-sectional telephonic surveySemantic proximity
Risk of severe COVID-19 in patients with inflammatory rheumatic diseases treated with immunosuppressive therapy in ScotlandSemantic proximity
Select a neighboring publication to make it the new centre.